I don’t have a problem with the numbers, but your assessment is off.
Swine flu killed 12,000. Influenza kills 4x’s that every year on average. The reason he shut down movement from current hot spots is to reduce the spread. The expectation of lowering the number of cases by refusing entrance to America from those areas is not a drastic measure, but just common sense.
There is no ulterior motive behind this move and it does not suggest a bigger problem than what we can actually see. I’ll refrain from saying it’s a nothing burger, but it ain’t a double with cheese either.
There is no ulterior motive behind this move and it does not suggest a bigger problem than what we can actually see. I’ll refrain from saying it’s a nothing burger, but it ain’t a double with cheese either.
Exactly.
The entire point behind slowing the spread is to buy time to develop treatments. Since we already have existing drugs that show promising results inhibiting progress of the disease and limiting viral replication, if we can buy 1-2 more months we may be able to determine if this is the best course of action. And, if so, then we can go from clinical trials to eventually providing therapy to patients infected with the disease in the coming months.
If it turns out to have a higher than normal lethality rate, then we'll have bought time for treatment. If not, then we've bought time to treat the cases that don't have good outcomes and reduce the overall population getting sick.
I don’t have a problem with the numbers, but your assessment is off.
Swine flu killed 12,000. Influenza kills 4x’s that every year on average. The reason he shut down movement from current hot spots is to reduce the spread. The expectation of lowering the number of cases by refusing entrance to America from those areas is not a drastic measure, but just common sense.
There is no ulterior motive behind this move and it does not suggest a bigger problem than what we can actually see. I’ll refrain from saying it’s a nothing burger, but it ain’t a double with cheese either.
Exactly.
The entire point behind slowing the spread is to buy time to develop treatments. Since we already have existing drugs that show promising results inhibiting progress of the disease and limiting viral replication, if we can buy 1-2 more months we may be able to determine if this is the best course of action. And, if so, then we can go from clinical trials to eventually providing therapy to patients infected with the disease in the coming months.
If it turns out to have a higher than normal lethality rate, then we'll have bought time for treatment. If not, then we've bought time to treat the cases that don't have good outcomes and reduce the overall population getting sick.
What President Trump is doing is really a win-win